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Objective: to compare the incidence of vascular complications in patients undergoing transfemoral 
cardiac catheterization with a 6F introducer sheath followed by 3-hour versus 5-hour rest. 
Methods: randomized clinical trial. Subjects in the intervention group (IG) ambulated 3 hours 
after sheath removal, versus 5 hours in the control group (CG). All patients remained in the 
catheterization laboratory for 5 hours and were assessed hourly, and were contacted 24, 48, 
and 72 h after hospital discharge. Results: the sample comprised 367 patients in the IG and 363 
in the GC. During cath lab stay, hematoma was the most common complication in both groups, 
occurring in 12 (3%) IG and 13 (4%) CG subjects (P=0.87). Bleeding occurred in 4 (1%) IG and 
6 (2%) CG subjects (P=0.51), and vasovagal reaction in 5 (1.4%) IG and 4 (1.1%) CG subjects 
(P=0.75). At 24-h, 48-h, and 72-h bruising was the most commonly reported complication in 
both groups. None of the comparisons revealed any significant between-group differences. 
Conclusion: the results of this trial show that reducing bed rest time to 3 hours after elective 
cardiac catheterization is safe and does not increase complications as compared with a 5-hour 
rest. ClinicalTrials.gov Identifier: NCT-01740856
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Introduction
The rate of complications after femoral artery 
puncture for coronary angiography or diagnostic cardiac 
catheterization ranges from 1.5% to 3.7%, with vascular 
complications having the highest incidence(1). Particularly 
in the first 6 to 12 hours after a transfemoral procedure, 
care of the insertion site is a determining factor in the 
occurrence or mitigation of these complications and a 
reminder of the constant vigilance that these patients 
require(2). 
Despite rapid advancement in techniques, 
catheters, contrast agents, and implantable devices, 
post-catheterization nursing care has not evolved at 
a similar pace, and remains classically based on bed 
rest, which may last 2 hours(3) to 24 hours(4). A recent 
meta-analysis of 20 studies and 4,019 patients found 
that a bed rest duration of 2–3 hours after transfemoral 
catheterization is safe, has no effect on the incidence of 
vascular complications, and may reduce back pain and 
discomfort(5).
Although the literature suggests that early 
mobilization is safe after diagnostic catheterization, 
studies are unclear as to the setting of this 
intervention. Furthermore, the only study on shorter 
bed rest conducted in Brazil was carried out at a private 
clinic(6); therefore, its results cannot be extrapolated 
to a large, high-complexity teaching hospital, which 
was the proposed setting for the present study. In 
addition, at the facility where the present study was 
carried out, transfemoral diagnostic catheterization 
is performed by multiple operators, ranging from 
experienced physicians to residents in training, and 
is followed by a standard 5-hour rest period. This 
study is relevant insofar as it reports the results of an 
intervention that could be incorporated immediately 
into the clinical practice of a variety of health facilities 
with similar profiles. 
Within this context, the present randomized 
controlled trial (RCT) was designed to test the 
hypothesis that reducing the duration of bed rest to 3 
hours in the intervention group (IG) from 5 hours in 
the control group (CG) would not increase the rate of 
arterial puncture-related complications after elective 
transfemoral diagnostic cardiac catheterization with a 
6F introducer sheath.
Methods
This is a report of the THREE CATH (Reducing rest 
time to THREE hours after cardiac CATheterization does 
not increase complications related to the procedure) RCT, 
registered at ClinicalTrials.gov with accession number 
NCT-01740856, with blinded outcome assessment. This 
trial was conducted at the catheterization laboratory 
(cath lab) of a public university hospital located in the 
greater Porto Alegre area, state of Rio Grande do Sul, 
Brazil, from January 2011 to September 2013. 
Participants
The study sample comprised adult outpatients 
who underwent elective transfemoral diagnostic cardiac 
catheterization with a 6F introducer sheath. The 
exclusion criteria were any restrictions to ambulation, 
use of coumarin anticoagulants, body mass index (BMI) 
> 35kg/m2, hypertension with a systolic blood pressure 
(SBP) > 180mmHg or diastolic blood pressure (DBP) > 
110mmHg at the end of the procedure, and a history of 
uncontrolled bleeding. 
The study protocol was approved by the Research 
Ethics Committee of the facility where the trial was 
carried out. All patients were informed of the objectives 
of the study and were only included after having read 
and signed an informed consent form.
Study protocol and group allocation
Patients who met the inclusion criteria and were 
considered eligible were invited to take part in the 
study. At the end of the procedure, patients were taken 
to the observation unit (OU). Removal of the introducer 
sheath with hemostasis valve and manual (digital) 
compression of the insertion site for 15 minutes were 
performed by the nursing staff in both groups. Patients 
were instructed to refrain from moving the affected leg. 
After the second hour of bed rest, the nursing team 
contacted the unit secretary to be informed of patient 
randomization. All interventions were performed by the 
nursing staff, which had been duly trained to carry out 
all actions in a consistent manner in accordance with the 
study protocol.
Data on pre- and post-procedure clinical condition 
and clinical parameters of interest (sex, age, BMI, 
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diabetes, hypertension, peripheral vascular disease, 
current antiplatelet therapy) from patients in both 
groups (IG and CG) were recorded.
Intervention group
Patients randomly allocated to the intervention group 
(IG) remained in bed, in the supine position, for 2 hours 
after completion of manual (digital) compression. After 
this period, the nursing staff initiated the intervention by 
elevating the head of bed at 45 degrees for 60 minutes 
and making the patients ambulate around the cath lab 
for approximately 10 minutes. The staff than instructed 
patients to remain seated out of bed in the cath lab until 
the end of the 5-hour rest period, at which time patients 
were discharged and walked out of the hospital.
Control group
Participants randomly allocated to the CG remained 
in bed, in the supine position, for 4 hours after completion 
of the manual compression period. After this period, 
patients remained with the head of bed elevated at 45 
degrees for 60 minutes and were made to ambulate 
around the cath lab for 10 minutes. Patients were then 
discharged and walked out of the hospital.
Both groups received post-procedural care guidance 
and were monitored hourly by the nursing staff. Patients 
were notified that they would be contacted by telephone 
24, 48, and 72 hours after hospital discharge, and were 
given an instruction sheet containing descriptions and 
illustrative images of bleeding, hematoma, bruising, and 
pseudoaneurysm, as well as a ruler, with which they could 
measure any visible complications at the puncture site. 
Primary outcome
The primary outcome was occurrence 
of complications (hematoma, bleeding, and 
pseudoaneurysm), defined as follows:
1) Hematomas at the arterial puncture site, 
classified in accordance with the American College 
of Cardiology definition (large, > 10 cm; small, < 10 
cm)(7);
2) Major bleeding, as defined for the Evaluating the 
Performance of the Can Rapid Risk Stratification of Unstable 
Angina Patients Suppress Adverse Outcomes With Early 
Implementation of the ACC/AHA Guidelines (CRUSADE) 
bleeding score trial: documented retroperitoneal 
bleeding (not requiring surgical correction) or any red 
blood cell transfusion with witnessed bleed(8). Patients 
who developed hemodynamic instability, defined as 
uncontrolled hypertension or hypotension, tachycardia 
or bradycardia, or desaturation from baseline, were also 
considered to have major bleeding. If no hemodynamic 
instability occurred, bleeding was considered minor(8);
3) Any of the following vascular complications 
requiring surgical correction: retroperitoneal bleeding, 
pseudoaneurysm, or development of arteriovenous fistula(9). 
Secondary outcomes
The secondary outcomes of interest were 
vasovagal response to sheath withdrawal, bruising, 
association/comparison between current medications 
and comorbidities, and association/comparison between 
sex and events during OU stay and at 24-, 48-, and 72-
hour follow-up.
Sample size calculation
The sample size calculation was based on the 
assumption that the proportion of events would not 
be higher in IG than in CG participants. Considering 
a negligible difference between the intervention and 
control group, a 2% rate of events, and a 20% attrition 
rate, the minimum sample size was estimated at 714 
patients for an alpha level of 0.05 and 80% statistical 
power(9). Overall, 48 participants (6.6%) were lost to 
follow-up, for a final sample size of 730.
Randomization
The website www.randomization.com was used 
to generate a simple random numbers list, which was 
managed by a person not involved in the trial (cath lab 
secretary) responsible for patient allocation into IG and 
CG. Participants were always randomized at hour 2 of 
bed rest at the OU after the procedure. At that time, the 
cath lab secretary was instructed by the nursing team 
to check the randomization list and state the group to 
which the patient should be allocated.
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Blinding
The interventional radiology team and cath lab 
nursing staff were blinded to group allocation until the 
second hour of bed rest. Outcome monitoring during 
OU stay was carried out by the nursing team, whereas 
outcome assessment by telephone was performed by a 
provider blinded to group allocation.
Statistical analysis
Variables were entered into a Microsoft Excel 
spreadsheet and analyzed in PASW Statistics 18. 
Continuous variables were expressed as means and 
standard deviations if normally distributed, and 
categorical variables were expressed as absolute number 
and relative frequencies. Student’s t-test was used for 
between-group comparisons of normally distributed 
quantitative variables. Pearson’s chi-square test was 
used with the same purpose for categorical variables, 
as well as to test for potential associations of current 
medications and comorbidities with occurrence of the 
events of interest. Relative risks with respective 95% 
confidence intervals were calculated to assess the effect 
size of the intervention. Two-tailed P-values < 0.05 were 
considered significant.
Results
From January 2011 to September 2013, 2,827 
patients underwent elective  diagnostic catheterization 
with a 6F introducer sheath at the study facility. Of 
these, 387 met at least one of the exclusion criteria and 
were thus left out of the sample. High blood pressure 
at the time of randomization (SBP ≥ 180mmHg or DBP 
≥ 110mmHg at the end of the procedure) was the 
leading reason for exclusion, followed by motor issues 
that hindered ambulation and, at lower rates, obesity 
and use of coumarin anticoagulants and heparin. Thirty-
seven patients dropped out of the study, and 1,673 were 
excluded for other reasons, including hospitalization at 
the time of diagnostic catheterization (n=669, 40%), 
transradial catheterization (n=602, 36%) and, at lower 
rates, cognitive impairment, right heart catheterization, 
and logistical issues. Overall, 730 participants were 
randomized: 367 into the IG and 363 into the CG (Figure 
1).
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Figure 1 - Consolidated Standards of Reporting Trials (CONSORT) flow diagram 
Sample profile
Table 1 illustrates the profile of the intervention and 
control groups at baseline. Mean age was similar in both 
groups, and both were composed predominantly of female 
participants. Diabetes mellitus (DM) and hypertension 
(HTN) were the most prevalent comorbidities. Overall, 
the groups were homogeneous for all variables. 
Table 1 – Demographic and clinical profile of patients undergoing diagnostic cardiac catheterization with a 6F 
introducer sheath. Porto Alegre, RS, Brazil, 2013
Variable Overall(n=730)
Intervention group
(n=367)
Control group
(n=363) P
Age, years 62 ± 11 61.5 ± 11 63 ± 10 0.14*
Females, n (%) 407 (56) 211 (57.5) 196 (54) 0.34 †
Weight, kg 76 ± 14 75 ± 14 76 ± 13 0.76*
Height, cm 163 ± 10 163 ± 10 164 ± 9 0.32*
Body mass index, kg/m2 28 ± 4 28 ± 4 28 ± 4 0.90*
Diabetes, n (%) 245 (34) 131 (36) 114 (31) 0.22 †
(continue...)
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Variable Overall(n=730)
Intervention group
(n=367)
Control group
(n=363) P
Hypertension, n (%) 616 (84) 310 (84.5) 316 (84) 0.94 †
Peripheral vascular disease, n (%) 23 (3) 14 (4) 9 (2.5) 0.30 †
Systolic blood pressure, mmHg 145 ± 25 145 ± 25 145 ± 25 0.74*
Diastolic blood pressure, mmHg 82 ± 13 81 ± 13 82 ± 13 0.49*
Current medications, n (%)
Aspirin 515 (70) 252 (69) 263 (72) 0,74†
Clopidogrel 153 (21) 74 (20) 79 (22) 059†
 ±: standard deviation; *: Student’s t-test; n (%): categorical variables; †: chi-square test.
Table 1 - (continuation)
Complications detected during observation unit stay
Table 2 lists the post-procedural complications 
observed throughout the OU stay period. Hematoma 
was the most common complication in both groups, with 
no significant difference. Relative risks and confidence 
intervals for hematoma and bleeding were RR = 0.91 
(95%CI 0.42-1.97) and RR = 0.66 (95%CI 0.19-2.32) 
respectively. The relative risk of vasovagal response 
was RR = 1.24 (95%CI 0.34-4.57). No comparison 
was statistically significant. None of the participants 
developed pseudoaneurysm or any other vascular 
complications during the observation period.
Table 2 – Complications after diagnostic cardiac catheterization detected during observation. Porto Alegre, RS, Brazil, 2013
Complication Overall(n = 730)
Intervention group
(n = 367)
Control 
group
(n = 363)
*P RR (95%CI)
Hematoma, n (%) 25 (3.4) 12 (3.3) 13 (3.6) 0.87 0.91 (0.42-1.97)
Bleeding, n (%) 10 (1.4) 4 (1.1) 6 (1.7) 0.51 0.66 (0.19-2.32)
Vasovagal response, n (%) 9 (1.2) 5 (1.4) 4 (1.1) 0.75 1.24 (0.34-4.57)
*P: Pearson’s chi-square test; RR: relative risk; 95%CI: confidence interval.
Complications detected at 24-hour, 48-hour, and 72-
hour follow-up
At 24-, 48-, and 72-hour telephone follow-
up, the majority of participants in both groups were 
complication-free. Overall, 48 participants (7%) were 
lost to 24-hour follow-up (22 IG and 26 CG). Thus, 345 
IG group and 337 CG participants remained for analysis 
and were contacted at 48 hours and 72 hours.  
Bruising was the most prevalent complication at all 
three time points in both groups, followed by pain at 
insertion site (Table 3). Hematoma was the third most 
prevalent complication during this period. Only one 
participant (0.3%), allocated to the CG, had developed 
a pseudoaneurysm at 48-hour follow-up and required 
in-hospital treatment. There were no significant 
between-group differences in prevalence of any of the 
complications assessed.
Table 3 – Complications after diagnostic cardiac catheterization detected during home follow-up at 24, 48, and 72 
hours. Porto Alegre, RS, Brazil, 2013
Complication 24 hoursn (%)
48 hours
n (%)
72 hours
n (%)
None
Intervention group 206 (59.4) 203 (58.8) 204 (59.1)
Control group 200 (59.3) 199 (59.1) 205 (60.8)
Bruising
Intervention group 102 (29.6) 112 (32.5) 116 (33.6)
Control group 97 (28.8) 113 (33.5) 114 (33.8)
(continue...)
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Table 3 - (continuation)
Complication 24 hoursn (%)
48 hours
n (%)
72 hours
n (%)
Pain
Intervention group 29 (8.4) 23 (6.7) 19 (5.5)
Control group 33 (9.8) 21 (6.2) 14 (4.2)
Hematoma
Intervention group 8 (2.3) 7 (2.0) 6 (1.7)
Control group 7 (2.1) 3 (0.9) 3 (0.9)
P* 0.841 0.619 0.612
*P: Pearson’s chi-square test
Associations between antiplatelet therapy or 
comorbidities and development of complications
Among patients who were on clopidogrel or 
aspirin, use of these agents was not associated with 
complications. Likewise, the presence of HTN, DM, or 
peripheral vascular disease was not associated with any 
of the events of interest.
Associations between sex and development of 
complications during observation unit stay and at 
24-hour, 48-hour, and 72-hour follow-up
During OU stay, event rates were similar in male 
and female participants, regardless of group (P=0.250). 
At 24-, 48-, and 72-hour telephone follow-up, the 
pooled event rate (bruising, pain, hematoma) was 
significantly higher in women (n=156, 41%) than in men 
(n=92, 30%) (P=0.004). Between-group comparison 
of the occurrence of events during OU stay showed no 
significant difference between IG and CG (P=0.691). 
This finding remained unchanged during follow-up in 
both groups (P=0.888).  
Discussion
This RCT was the first study conducted in a 
public teaching hospital in Latin America to test the 
hypothesis that reducing bed rest from 5 to 3 hours 
after transfemoral diagnostic catheterization with a 6F 
introducer sheath would be safe and would not increase 
the rate of arterial puncture-related complications. 
As a result of reducing the duration of bed rest from 
5 to 3 hours, involving multiple operators with different 
learning curves for arterial puncture and insertion 
site hemostasis, there was no increase in the rate of 
hematoma, bleeding, pseudoaneurysm, vasovagal 
response, or other complications during OU stay. 
Likewise, at 24-hour, 48-hour, and 72-hour telephone 
follow-up, the majority of participants were free of 
complications. Among patients who were on clopidogrel 
or aspirin, use of these medicines was not associated 
with occurrence of complications. The presence of 
comorbidities was also not associated with increased 
risk of complications at any time during follow-up. 
In both groups, the most common vascular 
complication during OU stay was puncture site hematoma 
(no significant between-group difference), followed by 
bleeding and vasovagal response. However, at 24-hour, 
48-hour, and 72-hour telephone follow-up, it was the 
complication least reported by patients. The literature 
suggests that the incidence of arterial access-related 
hematoma ranges from 0.1 to 9%, with hematomas 
graded as large if > 10cm or small if < 10cm(10). 
In a meta-analysis of 20 studies and 4,019 patients 
that sought to assess the effects of bed rest duration 
after transfemoral cardiac catheterization, the incidence 
of hematoma was approximately 7.6%(5). It should 
be noted that the included studies employed different 
introducer sheath sizes, ranging from 4F to 9F. Some 
authors have reported that female patients are more 
prone to developing hematoma(6,11-12). Characteristics 
such as body surface area, vessel size, increased 
sensitivity to anticoagulants and antiplatelet agents, or 
hormonal differences may explain this predilection(12-13). 
In the present RCT, regardless of group allocation, 
women reported significantly more events than men 
at 24-hour, 48-hour, and 72-hour telephone follow-up, 
which corroborates the existing literature.
Puncture site bleeding was the second most 
common complication in both groups during OU stay; 
conversely, no cases were reported at 24-hour, 48-hour, 
and 72-hour telephone follow-up. All bleeding episodes 
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occurred in participants still resting in bed at the OU and 
as soon as participants began to ambulate, after the time 
frame stipulated for each group. Bleeds were classified 
as minor and exhibited similar clinical characteristics in 
both groups. In one study of 80 patients undergoing 
transfemoral diagnostic cardiac catheterization with a 
4F introducer sheath with hemostasis valve, where 40 
patients ambulated after 2 hours and 40 after 4 hours, 
three patients developed bleeding in the 4-hour group, 
versus none in the 2-hour group(14). With the advent 
of increasingly potent anticoagulant therapies and 
antiplatelet agents designed to reduce the incidence of 
periprocedural ischemic complications, a reassessment 
of bleeding risk is in order. Early identification of 
hematoma or bleeding requires knowledge, skill, and 
rapid intervention by the nursing team. Supervision 
and continued training of nurses can help ensure rapid 
identification and treatment of this complication, thus 
benefiting patient safety. 
Another complication observed only during OU stay 
was vasovagal reaction, which occurred in 5 (1.4%) 
IG participants and 4 (1.1%) CG participants. Similar 
results regarding this complication were observed in a 
study conducted at a university hospital in Australia(15). 
Of the 611 patients analyzed, 35 (5.7%) developed 
this complication during sheath removal. Vasovagal 
responses triggered by anxiety or pain now occur in 
fewer patients, possibly due to widespread awareness 
of the nature of cardiac catheterization (thus reducing 
patient tension), better care by multidisciplinary 
teams, more effective sedation, and greater operator 
experience(1). The malaise caused by prolonged supine 
positioning and immobility, compounded by difficulty 
urinating, pelvic discomfort, and anxiety, are predictors 
of vasovagal response during sheath withdrawal(15). 
Within this context, shortening the duration of bed rest 
may reduce this complication. 
In both groups, bruising at the insertion site 
was the most commonly reported complication at 
telephone follow-up, followed by pain and hematoma. 
In a study(3) of 1,446 patients undergoing diagnostic 
cardiac catheterization with a 6F introducer sheath with 
hemostasis valve, there were no major bleeding events 
or large hematomas, only bruising (in 10% and 21% of 
IG and CG patients respectively) and small hematomas 
(22% and 9% of IG and CG patients respectively) 
after discharge. Thus, the authors concluded that early 
ambulation was safe in their patient population(3). 
Patients who have undergone cardiac catheterization 
experience restricted mobility due to arterial puncture 
of the catheterized limb. Back pain and discomfort 
secondary to immobilization are often recorded by cath 
lab nurses, and are the most common complaints of 
patients in this setting(13). Nursing care should focus on 
patients’ difficulties and judicious monitoring. Studies of 
patients undergoing interventional radiology procedures 
have demonstrated that duration of bed rest is 
associated with discomfort(2,6,12-13,16). Indeed, discomfort 
and impatience have been observed in patients during 
the recovery period, both while in hospital and after 
discharge to home. Pain and discomfort was the second 
most common complication (complaint) at 24-hour, 48-
hour, and 72-hour follow-up. A Swedish study(11) that 
assessed this complication up to 3 days post-procedure 
found that shortening the immobilization period had 
beneficial effects on patient comfort and satisfaction. 
Prolonged rest can cause muscle weakness and fatigue 
due to constant pressure over the same muscle groups, 
and fatigue can, in turn, lead to muscle spasms and 
back pain. These authors also reported that reducing 
the duration of bed rest can reduce back pain and 
discomfort without increasing vascular complications. 
In this setting, early ambulation is a particularly 
relevant additional strategy to improve patient comfort 
after cardiac catheterization procedures. In the 
present sample, antiplatelet therapy and presence of 
comorbidities were not associated with increased risk of 
complications. 
In short, the strategy tested in this trial – i.e., 
reducing duration of bed rest after diagnostic cardiac 
catheterization to 3 hours – proved feasible and safe. 
Reduction of cath lab length of stay is consistent with 
a focus on resource optimization and can help meet 
the growing demand for procedures. Trials such as this 
are necessary if providers are to abandon care routines 
for which there is no evidence basis and change their 
practices, using consistent results from large-scale RCTs 
as a reference.
Conclusions
Based on the results of this RCT, we conclude 
that reducing the duration of bed rest from 5 to 3 
hours in patients undergoing transfemoral diagnostic 
cardiac catheterization with a 6F introducer sheath 
did not increase the rate of arterial puncture-related 
complications during OU stay or at 24-hour, 48-hour, 
and 72-hour telephone follow-up. Antiplatelet therapy 
(clopidogrel and aspirin) and presence of comorbidities 
(HTN, DM, and DVP) were not significantly associated 
with occurrence of the clinical outcomes of interest at 
any point during the study period. Women, regardless of 
group allocation, experienced more events than men at 
24-hour, 48-hour, and 72-hour follow-up.
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